A phase II study of avelumab monotherapy in patients with mismatch repair-deficient/microsatellite instability-high or POLE-mutated metastatic or unresectable colorectal cancer - Kim, J H; Kim, S Y; Baek, J Y (Cancer Res Treat, 2020)